Cargando…
In Vivo Effects of Bradykinin B(2) Receptor Agonists with Varying Susceptibility to Peptidases
We reported evidence of bradykinin (BK) regeneration from C-terminal extended BK sequences that behave as peptidase-activated B(2) receptor (B(2)R) agonists. Further to these in vitro studies, we carried out in vivo experiments to verify hemodynamic effects of BK analogs exhibiting variable suscepti...
Autores principales: | Jean, Mélissa, Gera, Lajos, Charest-Morin, Xavier, Marceau, François, Bachelard, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709452/ https://www.ncbi.nlm.nih.gov/pubmed/26793104 http://dx.doi.org/10.3389/fphar.2015.00306 |
Ejemplares similares
-
Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B(2) receptor: application to cytofluorometry and imaging
por: Gera, Lajos, et al.
Publicado: (2016) -
D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
por: Bachelard, Hélène, et al.
Publicado: (2018) -
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B(2) receptor agonists
por: Charest-Morin, Xavier, et al.
Publicado: (2014) -
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats
por: Charest-Morin, Xavier, et al.
Publicado: (2017) -
In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020)